Dow Down 0.92% Nasdaq Down 0.83%

Curis, Inc. (CRIS)

-NasdaqGM
1.37 0.02(1.44%) Oct 22, 4:00PM EDT
Prev Close:1.39
Open:1.39
Bid:0.97 x 100
Ask:1.47 x 200
1y Target Est:5.43
Beta:1.18
Next Earnings Date: 3-Nov-14CRIS Earnings announcement
Day's Range:1.34 - 1.40
52wk Range:1.19 - 4.47
Volume:229,138
Avg Vol (3m):602,362
Market Cap:117.83M
P/E (ttm):N/A
EPS (ttm):-0.16
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CRISDown 1.44%117.83M
EXEL310.22M
INFI617.53M
PFE179.45B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8.07
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.19
Quarterly EPS Est (Sep-14) :-0.04
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Curis, Inc. is engaged in the research, development, and commercialization of cancer therapeutics. It focuses on developing cancer drug candidates, including CUDC-907, an oral, small molecule drug candidate that is designed to inhibit histone deac... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback